Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
Journal of Clinical Oncology (JCO) Podcast · Jason R. Westin
July 14, 20169m 21s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monotherapy in patients with relapsed or refractory hematologic malignancies.